No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CELU241220C500
- 0.00
- 0.000.00%
15min DelayClose Dec 11 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest0.50Strike Price0.00Turnover0.00%IV-78.45%PremiumDec 20, 2024Expiry Date1.82Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.48Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
10-Q: Q3 2024 Earnings Report
Celularity Gets Back On Track With Quarterly Submissions; Q3 Revenue Jump 145%
Express News | Celularity Inc: Filed Quarterly Report on Form 10-Q for Period Ended Sept 30, & Now Current With Quarterly Report Filings
Express News | Celularity Reports Over Sevenfold Growth in Net Product Sales Through Third Quarter 2024 Compared to Third Quarter 2023
Press Release: Celularity Reports Over Sevenfold Growth in Net Product Sales Through Third Quarter 2024 Compared to Third Quarter 2023
Celularity's Strategic Partner Announces Groundbreaking For Stem Cell & Regenerative Medicine Center In Asia Pacific